Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Autoimmune Disease
100%
Colombia
54%
Autoimmunity
54%
Polyautoimmunity
37%
Neutrophil Extracellular Traps
36%
Sjgren's Syndrome
34%
Latin America (LATAM)
30%
Polymyalgia Rheumatica
27%
Sicca
27%
Minor Salivary Gland Biopsy
27%
Focus Measure
27%
Multisystem Inflammatory Syndrome in children (MIS-C)
27%
Arthralgia
27%
Anti-Ro
27%
COVID-19
27%
Kawasaki Disease
27%
Constitutional Symptoms
27%
Early Diagnosis
27%
Viral Risk
27%
Bystander Activation
27%
Ebola Virus Disease
27%
Ebola Virus
27%
Re-emerging
27%
Disease-based
27%
Trampas
27%
Rheumatoid Arthritis
18%
Autoantibodies
18%
Virus
18%
Environmental Factors
18%
Systemic Lupus Erythematosus
16%
Early Treatment
13%
Multiple Organs
13%
World Population
13%
Internal Organs
13%
Treatment Initiation
13%
Physical Mobility
13%
Organ Loss
13%
Comorbidity
13%
Clinical Management
13%
Disease Stage
13%
Patients with Autoimmune Diseases
13%
Medical Specialty
13%
Inflammatory Milieu
13%
European League against Rheumatism (EULAR)
10%
Virion-incorporated Proteins
9%
Cosignaling
9%
Co-host
9%
Xenobiotic Chemicals
9%
Autoimmune Phenomena
9%
Disease Control
9%
Global Health
9%
West Africa
9%
Uveitis
9%
Epigenetic Factors
9%
Clinical Treatment
9%
Genetics/epigenetics
9%
Rapid Dissemination
9%
Health Anxiety
9%
Cytokine Storm
9%
Molecular Mimicry
9%
Etiology
9%
Autoimmune Ecology
9%
Protective Effect
9%
Variable Latency
9%
Risk Effects
9%
Organ-specific
9%
Chemical Drugs
9%
Spreading Activation
9%
Epitope Spreading
9%
Drug Factors
9%
Autoreactive B Cells
9%
Antigen-independent
9%
Nutritional Factors
9%
Neighboring Cells
9%
Clinical Manifestations
9%
Spondyloarthritis
9%
Molecular Biology
9%
Reston Ebolavirus
9%
Autoimmune
9%
Zaire Ebolavirus
9%
Chemical Factors
9%
Ebola Survivors
9%
Negative-strand RNA
9%
Clinical Expression
9%
T Cells
9%
Glycoprotein
9%
Sudan Ebolavirus
9%
Disease Syndrome
9%
Post-Ebola
9%
Filoviridae
9%
Nucleoprotein
9%
Bundibugyo Ebolavirus
9%
Immune Tolerance
9%
Genetic Factors
9%
New Conditions
9%
RNA-dependent RNA Polymerase (RdRP)
9%
Latency Time
9%
Inflammatory Conditions
9%
Autoantigen
7%
Erythrocyte Sedimentation Rate
6%
Colombian Patients
6%
Clinical Diagnosis
6%
Giant Cell Arteritis
6%
Cardiac Involvement
6%
American College of Rheumatology
6%
Systematic Literature Review
6%
Malignancy
6%
Colombian
6%
Classification Criteria
5%
Immunology and Microbiology
Autoimmune Disease
88%
Autoimmunity
63%
Neutrophil Extracellular Traps
30%
Rheumatic Polymyalgia
27%
Ebola Virus
27%
Virus Infection
27%
Coronavirinae
27%
Kawasaki Disease
27%
Autoantibody
19%
Inflammatory Arthritis
13%
Infectious Agent
11%
Systemic Lupus Erythematosus
10%
Rheumatic Disease
10%
Physical Mobility
9%
Comorbidity
9%
Neutrophil
9%
Autoantigen
7%
Epitope
6%
B Cell
6%
Xenobiotic
6%
Immune Tolerance
6%
T Cell
6%
Erythrocyte Sedimentation Rate
6%
Molecular Mimicry
6%
Giant Cell Arteritis
6%
Antigen
6%
Systemic Scleroderma
6%
Virus
6%
Medicine and Dentistry
Diseases
33%
Systematic Review
27%
Coronavirinae
27%
Salivary Gland Biopsy
27%
Ro Antibody
27%
Serositis
27%
Constitutional Symptoms
27%
Kawasaki Disease
27%
Arthralgia
27%
Ebolavirus
27%
Virus Infection
27%
Autoimmunity
9%
Virus
6%